JUL 20, 2021 1:00 PM PDT

Artificial Intelligence Predicts Which Drug Candidates Will Be Successful In Clinical Trials

WRITTEN BY: Ryan Vingum

Researchers are leveraging artificial intelligence and machine learning to help improve the rate at which drugs move successfully from preclinical to clinical development.

According to some research, the overall success rate of potential drug candidates is relatively low; only a small percentage of drug candidates move successfully out of the preclinical (nonhuman) testing stage, and many more fail during other clinical phases. Researchers note many reasons for these failures, though it is often an efficacy question: it may work great on mice in a lab, but that success doesn’t always translate well to an actual patient in a clinic. 

Given how costly it can be to develop a compound and move it through clinical trials, only to have it fail, it’s clear new approaches are needed. Researchers have responded by developing an artificial intelligence methodology at the Center for Precision Computational System Network (PreCSN) that may help predict and choose drug candidates that will be successful in trials.

This methodology, recently described in a Nature Communications article, helps researchers accurately, and with great detail, map a disease and evaluate a potential drug candidate before it even enters preclinical studies. Researchers used their methodology to explore a complex disease, inflammatory bowel disease (IBD) and analyzed extensive information about different gene expressions that could cause IBD, allowing them to map gene variations that were applicable to any IBD patient. 

Using this data collected from the program, researchers were able to select a viable drug candidate that could target a common feature of IBD, leaky-gut cells, and used it to conduct a “Phase 0” study, a pre-preclinical investigation of a drug candidate. Researchers tested this drug candidate by collecting cells from biopsies performed on IBD patients and growing them in a dish to imitate actual leaky-gut tissue. Results showed that the cells grown in a dish were responsive to the drug candidate, even though the experiment was performed ex vivo. Their approach further used additional data (existing FDA trials of drugs with similar targets) to make predictions about the potential future success of the drug, highlighting the benefit of the AI methodologies’ predictive power.

"In head-to-head comparisons, we demonstrated the superiority of this approach over existing methodologies to accurately predict 'winners' and 'losers' in clinical trials," said Pradipta Ghosh, MD, one of the lead authors of the study.

The authors of the study note that next steps include further clinical development of the AI-identified drug candidate, which may shed light on whether this methodology could be useful for other diseases. 

 

Sources: Science Daily; Nature Communications

About the Author
  • Science writer and editor, with a focus on simplifying complex information about health, medicine, technology, and clinical drug development for a general audience.
You May Also Like
NOV 25, 2021
Cell & Molecular Biology
Analyzing Cells With Virtual Reality
NOV 25, 2021
Analyzing Cells With Virtual Reality
Research tools that are used to analyze gene expression have gotten cheaper, faster, and incredibly complex. An entire h ...
DEC 09, 2021
Chemistry & Physics
Quantum Spin Liquid Observed for the First Time Via Simulator
DEC 09, 2021
Quantum Spin Liquid Observed for the First Time Via Simulator
A new paper published in Science says that researchers at Harvard University have observed quantum spin liquids through ...
DEC 17, 2021
Space & Astronomy
'Hear' the Magenetosphere of One of Jupiter's Moons During a Juno Flyby
DEC 17, 2021
'Hear' the Magenetosphere of One of Jupiter's Moons During a Juno Flyby
During a flyby of Ganymede, a moon of Jupiter, the Juno spacecraft made a recording on June 7, 2021. The frequency of th ...
DEC 28, 2021
Space & Astronomy
Apollo 17 Moon Samples Illuminates Moon's Evolution
DEC 28, 2021
Apollo 17 Moon Samples Illuminates Moon's Evolution
The Apollo Moon missions not only succeeded in landing the first humans on the surface of our nearest planetary neighbor ...
DEC 30, 2021
Earth & The Environment
Ghost Gear is Haunting Marine Life
DEC 30, 2021
Ghost Gear is Haunting Marine Life
Fishing gear is the most prevalent pollution in the oceans. It makes up nearly 50% of the floating garbage in the Great ...
JAN 04, 2022
Drug Discovery & Development
Micro-robots that can deliver drugs to treat brain cancer
JAN 04, 2022
Micro-robots that can deliver drugs to treat brain cancer
Scientists have developed tiny, microscopic robots with the capability to swim through the bloodstream, enter the brain, ...
Loading Comments...